Faes Farma S.A [FAE] vs Almirall S.A [ALM] Detailed Stock Comparison

Faes Farma S.A

BME
Loading...

Almirall S.A

BME
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Faes Farma S.A wins in 13 metrics, Almirall S.A wins in 7 metrics, with 0 ties. Faes Farma S.A appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFaes Farma S.AAlmirall S.ABetter
P/E Ratio (TTM)12.47116.00Faes Farma S.A
Price-to-Book Ratio1.811.70Almirall S.A
Debt-to-Equity Ratio11.4826.47Faes Farma S.A
PEG Ratio14.6225.22Faes Farma S.A
EV/EBITDA11.0314.14Faes Farma S.A
Profit Margin (TTM)19.37%2.02%Faes Farma S.A
Operating Margin (TTM)18.19%3.22%Faes Farma S.A
EBITDA Margin (TTM)18.19%3.22%Faes Farma S.A
Return on Equity14.83%1.45%Faes Farma S.A
Return on Assets (TTM)6.92%1.56%Faes Farma S.A
Free Cash Flow (TTM)$75.88M$-664,000Faes Farma S.A
Dividend Yield6.64%1.67%Faes Farma S.A
1-Year Return14.29%31.07%Almirall S.A
Price-to-Sales Ratio (TTM)2.432.36Almirall S.A
Enterprise Value$1.29B$2.53BAlmirall S.A
EV/Revenue Ratio2.382.40Faes Farma S.A
Gross Profit Margin (TTM)69.26%91.07%Almirall S.A
Revenue per Share (TTM)$2$5Almirall S.A
Earnings per Share (Diluted)$0.34$0.10Faes Farma S.A
Beta (Stock Volatility)0.350.34Almirall S.A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Faes Farma S.A vs Almirall S.A Stock Performance Analysis

Loading Price Chart...

Faes Farma S.A
Almirall S.A
Faes Farma S.A Stock Overview | Almirall S.A Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Faes Farma S.A-0.47%0.47%-0.24%-6.19%20.11%20.80%
Almirall S.A-1.90%3.76%3.57%9.23%14.51%38.42%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Faes Farma S.A14.29%14.29%26.19%75.21%32.50%-47.13%
Almirall S.A31.07%17.65%20.08%-26.40%40.61%-22.77%

News Based Sentiment: Faes Farma S.A vs Almirall S.A

Faes Farma S.A

News based Sentiment: MIXED

September brought a blend of positive and negative developments for Faes Farma. While sales remain strong and analysts offer a positive outlook, a slight dip in net income and conflicting technical signals create uncertainty. The successful integration of SIFI SpA remains a critical factor for the company's future performance.

View Faes Farma S.A News Sentiment Analysis

Almirall S.A

News based Sentiment: POSITIVE

Almirall had a very positive month, showcasing significant advancements in its dermatology pipeline at the EADV Congress. This was reflected in a stock price increase of 1.78% and the stock nearing its 52-week high. The positive clinical data and pipeline developments suggest a strong outlook for future growth.

View Almirall S.A News Sentiment Analysis

Performance & Financial Health Analysis: Faes Farma S.A vs Almirall S.A

MetricFAEALM
Market Information
Market Cap i€1.31B€2.49B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i95,92886,754
90 Day Avg. Volume i92,951121,287
Last Close€4.22€11.38
52 Week Range€3.27 - €4.73€8.03 - €11.66
% from 52W High-10.78%-2.40%
All-Time High€19.40 (Feb 05, 2007)€19.09 (Dec 28, 2015)
% from All-Time High-78.25%-40.39%
Growth Metrics
Quarterly Revenue Growth0.15%0.10%
Quarterly Earnings Growth-0.14%-0.38%
Financial Health
Profit Margin (TTM) i0.19%0.02%
Operating Margin (TTM) i0.18%0.03%
Return on Equity (TTM) i0.15%0.01%
Debt to Equity (MRQ) i11.4826.47
Cash & Liquidity
Book Value per Share (MRQ)€2.34€6.81
Cash per Share (MRQ)€0.36€1.51
Operating Cash Flow (TTM) i€101.14M€152.00M
Levered Free Cash Flow (TTM) i€42.79M€39.89M
Dividends
Last 12-Month Dividend Yield i6.64%1.67%
Last 12-Month Dividend i€0.30€0.18

Valuation & Enterprise Metrics Analysis: Faes Farma S.A vs Almirall S.A

MetricFAEALM
Price Ratios
P/E Ratio (TTM) i12.47116.00
Forward P/E i14.6225.22
PEG Ratio i14.6225.22
Price to Sales (TTM) i2.432.36
Price to Book (MRQ) i1.811.70
Market Capitalization
Market Capitalization i€1.31B€2.49B
Enterprise Value i€1.29B€2.53B
Enterprise Value Metrics
Enterprise to Revenue i2.382.40
Enterprise to EBITDA i11.0314.14
Risk & Other Metrics
Beta i0.350.34
Book Value per Share (MRQ) i€2.34€6.81

Financial Statements Comparison: Faes Farma S.A vs Almirall S.A

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FAEALM
Revenue/Sales i€134.64M€286.10M
Cost of Goods Sold i€41.38M€94.20M
Gross Profit i€93.25M€191.90M
Research & Development iN/A€35.50M
Operating Income (EBIT) i€42.59M€34.20M
EBITDA i€42.59M€72.90M
Pre-Tax Income i€32.86M€35.80M
Income Tax i€5.01M€14.20M
Net Income (Profit) i€27.85M€21.60M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FAEALM
Cash & Equivalents i€103.36M€374.40M
Total Current Assets i€422.72M€764.60M
Total Current Liabilities i€184.27M€334.70M
Long-Term Debt i€63.63M€341.50M
Total Shareholders Equity i€730.04M€1.50B
Retained Earnings i€52.33MN/A
Property, Plant & Equipment i€317.80MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FAEALM
Operating Cash Flow iN/A€35.70M
Capital Expenditures iN/AN/A
Free Cash Flow iN/A€12.20M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFAEALM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i95,92886,754
Average Daily Volume (90 Day) i92,951121,287
Shares Outstanding i311.25M213.24M
Float Shares i256.60M78.20M
% Held by Insiders i0.13%0.65%
% Held by Institutions i0.20%0.16%

Dividend Analysis & Yield Comparison: Faes Farma S.A vs Almirall S.A

MetricFAEALM
Last 12-Month Dividend i€0.30€0.18
Last 12-Month Dividend Yield i6.64%1.67%
3-Year Avg Annual Dividend i€0.16€0.18
3-Year Avg Dividend Yield i2.25%1.97%
3-Year Total Dividends i€0.49€0.54
Ex-Dividend DateJul 03, 2025May 15, 2025